Instructions for Poslabin Lactulose 30 tablets
Pharmacological effect Poslabin Lactulose
Sent Lactulose has a mild laxative effect. It promotes the normalization of motor-evacuatory function of the gastrointestinal tract, supports the growth of normal microflora of the intestines. Lactulose is not broken down by digestive enzymes in the upper gastrointestinal tract, and in the same way reaches the lower parts of the colon, which contributes to the softening of caloric masses and the normalization of intestinal digestive disorders. Lactulose is a nutrient medium for bifido- and lactobacteria of the large intestine, selectively stimulating their growth. By actively breeding under the influence of lactulose, bifido- and lactobacilli produce organic acids, which leads to a reduction of the pH of the intestines and the suppression of the growth of pathogenic microorganisms.
Testimony Poslabin Lactulose
- Chronic constipation;
- hepatic encephalopathy (severe liver disease accompanied by neuropsychiatric disorders);
- salmonellosis (acute infectious gastrointestinal disease), except in generalised forms (salmonellosis accompanied by infection
- of pathogens in blood);
- Digestive disorders associated with putrefaction processes resulting from food poisoning in infants and children under 10
- years of age.
- Lactulose can be used in pregnant and breastfeeding women, babies older than 6 weeks, the elderly, as well as persons who
- have undergone resection of hemorrhoidal nodules (removal of swollen and inflamed rectal veins).
Contraindications
Increased receptivity to product. Galactosemia (hereditary disease characterized by accumulation of galactosis in the blood and a lag in physical and mental development).
Method of use and doses
The product dose is selected individually.
In the treatment of constipation, adults are usually prescribed 15 to 45 ml in the first three days, then transferred to a maintenance dose of 10-25 ml. It is better to take the drug once every day in the morning during meals. For babies and adolescents aged seven to fourteen years, the initial dose is fifteen ml, the maintenance ten ml.
In babies under seven years of age, the initial and maintenance dose is the same: at the age of one to six years - 5-10 ml, from six weeks to one year - five ml of syrup.
In the treatment of hepatic encephalopathy (coma/complete loss of consciousness, characterized by complete absence of body reactions to external stimuli/or precoma/incomplete loss of consciousness - the initial stage of coma development, characterized by the persistence of pain and reflex reactions/), the product is prescribed for 30-50 ml twice - three times a day; it is possible to increase the dose to 190 ml per day. To prevent the development of liver coma in patients with severe liver damage, the product is prescribed 25 ml of 3triraz per day. In the absence of a therapeutic effect lactulose may result in the subsequent use of neomycin. If such treatment is not effective, it is advisable to use a combination of lactulose and neomycin.
For salmonellosis - fifteen ml three times a day for 10-12 days, then, after a seven-day break, the course of treatment is repeated. If necessary, a third course of treatment can be carried out with the product in a dose of 30 ml three times a day.
The syrup can be diluted with water or juice.
If the product is used for more than six months, it should regularly monitor the levels of potassium, chlorine and carbon dioxide in the blood plasma
